Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-02-26 @ 12:21 AM
Study NCT ID:
NCT03053167
Status:
UNKNOWN
Last Update Posted:
2017-02-14
First Post:
2017-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients
Sponsor:
China Medical University, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12
Start Date Type:
None
Primary Completion Date:
2019-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-23
First Submit QC Date:
None
Study First Post Date:
2017-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-13
Last Update Post Date:
2017-02-14
Last Update Post Date Type:
ACTUAL